RDGAD · RIDGEFIELD ACQUISITION CORP
Substantial doubt about the company's ability to continue as a going concern.
“The Company has an accumulated deficit balance as of September 30, 2025 and net loss during the three and nine months ended September 30, 2025. These conditions, among others, raise substantial doubt about the Company's ability to continue operations as a going concern.”View the 10-Q filed Nov 7, 2025
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Price & Indicators
The closing range uses available history since Sep 17, 2025; less than a full year is stored.
Latest documents
Metrics snapshot
Useful current figures from the complete screener profile.
Equibles Rating
blended score · not investment adviceBlended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders BuyIllustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Shell Companies — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
RDGAD
this stock
RIDGEFIELD ACQUISITION CORP
|
$417,912 | — | — | — | — |
|
VYLR
Vylor Inc.
|
$48.09B | — | — | — | 2.1% |
|
CLUS
Cluster Group Holdings Ltd Co
|
$8.00B | — | — | — | — |
|
DMII
Drugs Made In America Acquisition II Corp.
|
$652.61M | +3.5% | — | — | 0.0% |
|
EVAC
EQV Ventures Acquisition Corp. II
|
$606.10M | +3.4% | — | — | 0.0% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| RDGAD | -99.5% | -99.4% | — | +26.1% | -94.4% |
| SPY | +0.4% | +2.9% | +24.5% | +0.4% | +14.2% |
| vs SPY | -99.9% | -102.3% | — | +25.6% | -108.6% |